Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II

Semin Thromb Hemost. 2021 Jun;47(4):333-337. doi: 10.1055/s-0041-1728775. Epub 2021 Jun 1.

Authors

Emmanuel J Favaloro¹, Giuseppe Lippi²

Affiliations

¹ Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, Westmead, Australia.
² Section of Clinical Biochemistry, University of Verona, Verona, Italy.

PMID: 34062596
DOI: 10.1055/s-0041-1728775

No abstract available

Publication types

Introductory Journal Article

MeSH terms

Anticoagulants / adverse effects
Anticoagulants / therapeutic use*
COVID-19 / blood*
COVID-19 / complications
Hemostasis / drug effects
Hemostasis / physiology*
Humans
SARS-CoV-2*
Thrombophilia / drug therapy
Thrombophilia / etiology*
Thrombosis / etiology
Thrombosis / prevention & control*

Substances

Anticoagulants